Saunders Michael E 4
4 · ALLOS THERAPEUTICS INC · Filed Jan 4, 2005
Insider Transaction Report
Form 4
Saunders Michael E
VP, Clinical Development
Transactions
- Purchase
Common Stock
2004-12-31$1.85/sh+2,500$4,633→ 2,500 total
Holdings
- 50,000
Stock Options (Right to buy)
Exercise: $1.90From: 2005-07-21Exp: 2014-07-21→ Common Stock (50,000 underlying) - 52,000
Stock Options (Right to buy)
Exercise: $2.99From: 2004-12-15Exp: 2013-12-15→ Common Stock (52,000 underlying)
Footnotes (1)
- [F1]Represents shares acquired under the Company's Employee Stock Purchase Plan.